Swiss Cerebral Palsy Registry
ConditionCerebral Palsy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0+
SponsorUniversity of Bern
About this trial
The Swiss-CP-Reg is a national patient registry that collects information on diagnosis, symptoms, treatment and follow-up of patients with cerebral palsy (CP) in Switzerland. It was first implemented in 2017 in the paediatric clinics in Basel, Bellinzona, Bern, Geneva, Lausanne, St. Gallen and Zurich. It is currently extended to all Swiss clinics and medical practices and adults will be invited to join the register in the coming years. The registry provides data for national and international monitoring and research. It supports research on CP in Switzerland and the exchange of knowledge between clinicians, researchers and therapists, with the goal to improve the treatment of children and adults with CP and optimizing their health and quality of life.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Who were diagnosed with CP, confirmation of the diagnosis at the age of 5 years is required
Who are born, treated for CP or living in Switzerland, and
Who gave informed consent
Disqualifiers
Pure muscular hypotonia
Neurometabolic diseases (e.g. neuronal storage diseases, leukodystrophies)
Other progressive neurological diseases (e.g. spinocerebellar ataxias, hereditary spastic paraplegia, Rett syndrome, epileptic encephalopathy)
Trial population
All individuals living, born, or treated with a diagnosis of cerebral palsy in Switzerland
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
15,000 Participants
are grouped into 1 trial groupGroup A: Patient population
Trial outcomes
Primary outcomes
1
Personal data
Registering patients personal data
Time frame
At diagnosis (age 0-5 years)2
Change in date of registration
Change in date of last consultation at physician for data collection
Time frame
Baseline medical information, follow-up data collection at regular intervals (at diagnosis, at age of 5, 10 and 15 years, and at the time of transition to adult care (18±2 years))3
Birth history neonatal care
Maternal birth history
Time frame
At diagnosis (age 0-5 years)4
Cause of change in vital status
what caused a change in patients vital status
Time frame
Baseline medical information, follow-up data collection at regular intervals (at diagnosis, at age of 5, 10 and 15 years, and at the time of transition to adult care (18±2 years))Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Bern
Lead sponsor
Schweizerische Stiftung für das cerebral gelähmte Kind
Collaborator
SwissPedNet
Collaborator
Source ClinicalTrials.gov